Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0476 Transporter Info
Gene Name	SLC7A9
Transporter Name	Glycoprotein-associated amino acid transporter b0, +AT1
Gene ID	11136
UniProt ID	P82251

Post-Translational Modification of This DT
Overview of SLC7A9 Modification Sites with Functional and Structural Information
Sequence	M G D T G L R K R R E D E K S I Q S Q E P K T T S L Q K E L G L I S G I S I I V G T I I G S G I F V S P K S V L S N T E A V G P C L I I W A A C G V L A T L G A L C F A E L G T M I T K S G G E Y P Y L M E A Y G P I P A Y L F S W A S L I V I K P T S F A I I C L S F S E Y V C A P F Y V G C K P P Q I V V K C L A A A A I L F I S T V N S L S V R L G S Y V Q N I F T A A K L V I V A I I I I S G L V L L A Q G N T K N F D N S F E G A Q L S V G A I S L A F Y N G L W A Y D G W N Q L N Y I T E E L R N P Y R N L P L A I I I G I P L V T A C Y I L M N V S Y F T V M T A T E L L Q S Q A V A V T F G D R V L Y P A S W I V P L F V A F S T I G A A N G T C F T A G R L I Y V A G R E G H M L K V L S Y I S V R R L T P A P A I I F Y G I I A T I Y I I P G D I N S L V N Y F S F A A W L F Y G L T I L G L I V M R F T R K E L E R P I K V P V V I P V L M T L I S V F L V L A P I I S K P T W E Y L Y C V L F I L S G L L F Y F L F V H Y K F G W A Q K I S K P I T M H L Q M L M E V V P P E E D P E
PTM type	X-Phosphorylation X: Amino Acid

Phosphorylation
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC7A9			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	15
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A9 Serine 15 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC7A9			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A9 Serine 18 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC7A9			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	25
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A9 Serine 25 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC7A9			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	169
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A9 Serine 169 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC7A9			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A9 Threonine 4 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC7A9			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A9 Threonine 23 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC7A9			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	24
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A9 Threonine 24 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC7A9			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	470
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC7A9 Threonine 470 has the potential to affect its expression or activity.

References
1	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
2	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
3	Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues. Nat Commun. 2012 Jun 6;3:876.
4	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5	Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-KappaB pathways in a model of chronic myeloid leukemia. Mol Oncol. 2018 May;12(5):630-647.
6	Selective Enrichment of Cysteine-Containing Phosphopeptides for Subphosphoproteome Analysis. J Proteome Res. 2015 Dec 4;14(12):5341-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence